CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris
Clinical trial NCT02189629 · COMPLETED
Trial details
- NCT number
- NCT02189629
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-23
- Primary completion
- 2017-02-23
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.